Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Econazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | USP2 | O75604 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | HTT | P42858 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | NPY2R | P49146 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | NPY1R | P25929 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Econazole SCHEMBL36214 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNAMEN1KMT2ATDP1 | |
| Econazole SCHEMBL3692069 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNAMEN1KMT2ATDP1 | |
| Econazole SCHEMBL29379555 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNAMEN1KMT2ATDP1 | |
| Econazole SCHEMBL20456409 | 1.00 | CYP3A4 (1.00) | CYP3A4LMNAMEN1KMT2ATDP1 | |
| Miconazole SCHEMBL8200081 | 0.95 | CYP3A4 (0.91) | CYP3A4LMNAMEN1KMT2ATDP1 | |
| Nitric Acid SCHEMBL11488271 | 0.93 | CYP3A4 (0.86) | CYP3A4LMNAMEN1KMT2ATDP1 | |
| Econazole SCHEMBL7602990 | 0.92 | IDO1 (1.00) | CYP3A4LMNAMEN1KMT2ATDP1 | |
| Econazole SCHEMBL20482166 | 0.92 | IDO1 (1.00) | CYP3A4LMNAMEN1KMT2ATDP1 | |
| Econazole SCHEMBL34499 | 0.92 | IDO1 (1.00) | CYP3A4LMNAMEN1KMT2ATDP1 | |
| Econazole SCHEMBL7602993 | 0.92 | IDO1 (1.00) | CYP3A4LMNAMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4375 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025264604-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | claimed |
| US-12303491-B2 | Econazole nitrate medical patch and methods of use thereof | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-05-20 | — | — | US | claimed |
| US-20250127711-A1 | COMPOSITION AND METHOD FOR TREATING FUNGAL SKIN CONDITIONS AND INFLAMMATION | CMPD LICENSING, LLC (US) | 2025-04-24 | — | — | US | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| WO-2025032112-A1 | METHODS FOR THE TREATMENT OF TYPE 2-MEDIATED DISEASES | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-02-13 | — | — | WO | claimed |
| CN-119013001-A | Topical aerosol foam | 阿尔库缇斯生物疗法股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| EP-4456877-A1 | TOPICAL AEROSOL FOAMS | Arcutis Biotherapeutics, Inc. (US) | 2024-11-06 | — | — | EP | claimed |
| US-12102712-B2 | Composition and method for treating fungal skin conditions and inflammation | CMPD LICENSING LLC (US) | 2024-10-01 | — | — | US | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| WO-1990011754-A1 | AEROSOLIZED AZOLE ANTIFUNGALS | FISONS PLC (GB) | 1990-10-18 | — | — | WO | claimed |
| EP-0103995-B1 | MEDICATED SUPPOSITORY | CILAG AG (CH) | 1990-04-11 | — | — | EP | claimed |
| US-4897269-A | Administration of drugs with multiphase liposomal delivery system | MEZEI ASSOCIATES LIMITED (CA) | 1990-01-30 | — | — | US | claimed |
| CN-1031648-A | Prevent mean that elastomeric material is made and manufacture method thereof | HUTCHINSON (FR) | 1989-03-15 | — | — | CN | claimed |
| US-4803066-A | SYNERGISTIC MIXTURE OF AN IMIDAZOLE OR TRIAZOLE COMPOUND AND SILVER SULFADIAZINE | SMITH & NEPHEW ASSOCIATED COMPANIES P.L.C. (GB) | 1989-02-07 | — | — | US | claimed |
| US-4761288-A | Multiphase liposomal drug delivery system | MEZEI ASSOCIATES LIMITED (CA) | 1988-08-02 | — | — | US | claimed |
| EP-0241175-A1 | Topical antimicrobial pharmaceutical composition comprising a silver compound and an azole | SMITH & NEPHEW plc (GB) | 1987-10-14 | — | — | EP | claimed |
| US-4698359-A | Medicated suppository | CILAG, AG (CH) | 1987-10-06 | — | — | US | claimed |
| EP-0125759-A2 | Topical composition of antibiotics for application to the mucosa | WARNER LAMBERT HOLLAND B.V. (NL) | 1984-11-21 | — | — | EP | claimed |
| EP-0103995-A2 | Medicated suppository | CILAG AG (CH) | 1984-03-28 | — | — | EP | claimed |